Three Genes May Help Distinguish RA From OA
Machine learning and cell-line validation identify candidate biomarkers for differentiating rheumatoid arthritis vs osteoarthritis
By
Andrea Surnit
April 22, 2026
Clinical Scorecard: Three Genes May Help Distinguish RA From OA
At a Glance
Category Detail
Condition Rheumatoid Arthritis vs Osteoarthritis Key Mechanisms Differential gene expression related to immune pathways Target Population Patients with suspected rheumatoid arthritis or osteoarthritis Care Setting Clinical and research settings
Key Highlights
Three genes identified: EPYC, MAGED1, LAP3 Good diagnostic performance with AUC values above 0.85 Support vector machine approach achieved 93% accuracy Findings suggest immune-related pathways are involved Further validation needed before clinical application Guideline-Based Recommendations
Diagnosis
Consider gene expression analysis for distinguishing RA from OA Management
Use caution in treatment decisions based on gene expression findings Monitoring & Follow-up
Monitor immune-related pathways in RA patients Risks
Misclassification may affect treatment decisions Patient & Prescribing Data
Patients with early-stage rheumatoid arthritis or osteoarthritis
Gene expression data may inform treatment strategies but requires further validation
Clinical Best Practices
Validate findings in independent clinical cohorts Conduct mechanistic studies to establish causation Integrate genetic insights with clinical assessments References
